Kusurinomadoguchi, Inc. (JP:5592)
:5592
Want to see JP:5592 full AI Analyst Report?
Top Page
Kusurinomadoguchi, Inc.
(5592)
Select Model
Select Model
Rating:68Neutral
Price Target:
¥2,981.00
▲(12.03% Upside)
Action:Reiterated
Date:05/15/26
The score is driven primarily by strong multi-year revenue and net income growth, offset by meaningful cash-flow and balance-sheet volatility (notably the 2025 cash outflow and large asset/debt swings). Technically, signals are mixed with neutral momentum, and valuation is reasonable (P/E ~15 with a modest yield), providing moderate support.
Positive Factors
Multi-year revenue & earnings growth
Sustained multi-year top-line and net income expansion indicates durable demand and scalable unit economics. Persistent revenue and profit growth supports reinvestment in the platform, improves ability to fund marketing and tech, and creates a structural base for margin expansion and strategic optionality.
Negative Factors
Large cash-flow outflow in 2025
A major negative cash-flow year undermines earnings quality and indicates significant working-capital or investment swings. Such episodes can force external financing, strain liquidity, and reduce predictability of cash available to sustain operations or fund growth, creating structural execution risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Multi-year revenue & earnings growth
Sustained multi-year top-line and net income expansion indicates durable demand and scalable unit economics. Persistent revenue and profit growth supports reinvestment in the platform, improves ability to fund marketing and tech, and creates a structural base for margin expansion and strategic optionality.
Read all positive factors
Kusurinomadoguchi, Inc. (5592) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥32.66B
Dividend Yield1.03%
Average Volume (3M)73.92K
Price to Earnings (P/E)9.3
Beta (1Y)0.77
Revenue Growth10.10%
EPS Growth42.31%
CountryJP
Employees505
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)N/A
Shares Outstanding11,458,582
10 Day Avg. Volume72,500
30 Day Avg. Volume73,916
Financial Highlights & Ratios
PEG Ratio0.22
Price to Book (P/B)2.41
Price to Sales (P/S)2.22
P/FCF Ratio9.34
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Kusurinomadoguchi, Inc. Business Overview & Revenue Model
Company Description
Kusurinomadoguchi, Inc. provides solutions for pharmacies and medical care in Japan. The company offers EPARK drug counter, a pharmacy/drugstore search and reservation site; matching site to buy and sell dead stock medicines at dispensing pharmaci...
How the Company Makes Money
Kusurinomadoguchi, Inc. generates revenue primarily through its online platform by serving as a mediation service between consumers and pharmacies. The company earns fees from pharmacies for facilitating prescription orders and connecting patients...
Kusurinomadoguchi, Inc. Financial Statement Overview
Summary
Income Statement
84
Very Positive
Balance Sheet
66
Positive
Cash Flow
57
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 11.48B | 12.33B | 11.20B | 8.72B | 7.42B | 6.49B |
| Gross Profit | 6.62B | 6.97B | 6.48B | 4.93B | 4.07B | 3.37B |
| EBITDA | 3.26B | 4.19B | 2.97B | 2.35B | 1.68B | 1.51B |
| Net Income | 2.18B | 2.95B | 2.03B | 870.92M | 391.45M | 515.61M |
Balance Sheet | ||||||
| Total Assets | 11.87B | 17.82B | 12.16B | 23.07B | 12.22B | 11.02B |
| Cash, Cash Equivalents and Short-Term Investments | 1.89B | 5.20B | 2.15B | 14.59B | 5.95B | 5.02B |
| Total Debt | 56.01M | 2.82B | 72.47M | 5.42B | 137.49M | 149.56M |
| Total Liabilities | 3.25B | 6.35B | 3.64B | 16.65B | 9.43B | 8.06B |
| Stockholders Equity | 8.55B | 11.35B | 8.45B | 6.37B | 2.70B | 2.45B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 2.93B | -5.37B | 999.21M | 1.57B | 2.58B |
| Operating Cash Flow | 0.00 | 2.95B | -5.33B | 2.63B | 3.10B | 3.66B |
| Investing Cash Flow | 0.00 | -2.30B | -1.80B | -1.79B | -1.54B | -541.10M |
| Financing Cash Flow | 0.00 | 2.22B | -5.36B | 7.81B | -635.39M | -564.83M |
Kusurinomadoguchi, Inc. Technical Analysis
Positive
2661.00
Price Trends
2573.88
Positive
2602.45
Positive
3048.22
Negative
Market Momentum
43.10
Negative
59.44
Neutral
82.60
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5592, the sentiment is Positive. The current price of 2661 is above the 20-day moving average (MA) of 2549.17, above the 50-day MA of 2573.88, and below the 200-day MA of 3048.22, indicating a neutral trend. The MACD of 43.10 indicates Negative momentum. The RSI at 59.44 is Neutral, neither overbought nor oversold. The STOCH value of 82.60 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:5592.
Kusurinomadoguchi, Inc. Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | ¥32.66B | 9.27 | ― | 1.03% | 10.10% | 42.31% | |
60 Neutral | ¥175.90B | 31.32 | ― | 0.43% | 20.95% | 13.39% | |
52 Neutral | ¥17.36B | -67.95 | ― | ― | -39.26% | -69.48% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | ¥71.00B | -232.45 | 5.76% | ― | 23.30% | -56.05% | |
44 Neutral | ¥2.41B | -4.65 | ― | ― | 18.86% | 38.80% |
* Healthcare Sector Average
JP:5592
Kusurinomadoguchi, Inc.
2,850.00
435.66
18.04%
JP:4480
Medley
2,169.00
-1,031.00
-32.22%
JP:4263
SUSMED,Inc.
1,029.00
437.00
73.82%
JP:4438
Welby Inc.
286.00
-63.00
-18.05%
JP:4483
JMDC Inc.
2,688.00
-438.79
-14.03%
Kusurinomadoguchi, Inc. Corporate Events
Kusurinomadoguchi Details Q3 FY2026 Results Framework and Revenue Definitions
Feb 20, 2026
Kusurinomadoguchi, Inc. released a transcript of its financial results briefing for the third quarter of the fiscal year ending March 31, 2026, led by President and Representative Director Koji Tsutsumi. The company clarified definitions of its ke...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.